Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Nov 26, 2017

How to Think About Corporate Tax Reform
Image Source: DonkeyHotey. Donald Trump and team are working hard to “Make America Great Again,” and lowering tax rates on corporations is a key initiative. Nobody knows for sure whether such efforts will come to fruition, but knowing how to use our research and understanding the fair value estimate range puts you ahead of the crowd, if it hasn’t already.

Nov 21, 2017

A “Terrible” Negative Alpha-Generating “Trade” and More
Let’s walk through some of the news before the Thanksgiving holiday, and one of the bigger missteps we made during 2017.

Nov 21, 2017

Roche’s Hemlibra Looks Very Promising
Image shown: Roche's shares caught some relief recently. We're big fans of clinical data reads. Thus far in 2017, we've posted updates on Roche, Shire Plc and Bioverativ--each with extensive aspirations in the field of hemophilia. In light of recent developments, a follow-up only seems appropriate as Roche’s Hemlibra is poised to disrupt the marketplace.

Nov 20, 2017

Valuentum’s “Home Runs” During 2017
Image Source: Keith Allison. We don’t take many swings, but when we do…

Nov 19, 2017

Nelson on Bogle, Part I
Image shown: An example illustrating how the dividend is a component of capital appreciation that otherwise would have been achieved had the dividend not been paid. Such a situation applies to both regular and special dividends. "The kind of commentary that makes broad generalizations about expectations of future returns is exactly why people are so eager to get into passive investment strategies. Since the 1920s, it seems as though the individual investor has assumed the stock market was rigged or impossible for average Joes to figure out, but instead of the "I'll get it next time" mentality that was present leading to the crash of '29, individual investors have "evolved" to the point that now the idea is if you can't beat the market, just buy the whole thing. Leaders like Bogle continue to take tremendous shortcuts in explaining forecasts, leaving the average investor like a student trying to copy math homework off a peer that didn't show his/her work. When the test comes around, and the problem is a bit different, the copier is up a creek." -- The Valuentum Team

Nov 19, 2017

Dividend Increases/Decreases for the Week Ending November 17
Let's take a look at companies raising/lowering their dividends this week.

Nov 18, 2017

Valuentum's Highest-Rated Economic Castles
Image Source: Dunrobin Castle; Golspie, Sutherland, John Haslam. A look at some of the highest-rated Economic Castles in our coverage universe.

Nov 17, 2017

Celgene Implodes
The pharma/biotech industry operates in a boom-bust environment where the market cap of a company can post a meteoric rise or suffer a precipitous fall based on the data published from recently completed clinical trials. The industry remains one of the most innovative fields, but the quest for new products leads to constant disruption and a subsequent spike in volatility. Of late, the volatility pendulum for Celgene has swung in favor of the bears with the company posting a costly phase 3 failure.

Nov 16, 2017

Cisco’s Shares Are Surging!
Image Source: Cisco. We received some fantastic news from newsletter portfolio idea Cisco. Shares are surging! Please tell me you knew that Cisco was one of our favorite ideas.

Nov 15, 2017

Buffalo Wild Wings Should Go Private and Hasbro Should Buy Mattel…But at the Right Price
Image Source: Hasbro. There is a lot happening across the M&A landscape as of late. Buffalo Wild Wings has reportedly received a go-private offer, while speculation is swirling that Hasbro is looking to gobble up Mattel. We like the prospects of both scenarios. However, price will always matter. Buffalo Wild Wings should hold out for the very best offer, while Hasbro should be very careful not to overpay for assets that may be past their prime.